Compare HLN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLN | SMTI |
|---|---|---|
| Founded | 2022 | 1982 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8B | 313.5M |
| IPO Year | 2021 | 2008 |
| Metric | HLN | SMTI |
|---|---|---|
| Price | $9.26 | $35.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 17.6M | 203.9K |
| Earning Date | 02-26-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $6.55 | $17.31 |
| Revenue Next Year | $4.42 | $12.48 |
| P/E Ratio | $49.05 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $8.65 | $16.05 |
| 52 Week High | $11.28 | $35.34 |
| Indicator | HLN | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 68.88 |
| Support Level | $9.08 | $33.99 |
| Resistance Level | $9.29 | N/A |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 42.65 | 62.32 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.